-$0.13 EPS Expected for TrueCar Inc (NASDAQ:TRUE) This Quarter

Share on StockTwits

Equities research analysts predict that TrueCar Inc (NASDAQ:TRUE) will post ($0.13) earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Three analysts have issued estimates for TrueCar’s earnings. The lowest EPS estimate is ($0.18) and the highest is ($0.05). TrueCar posted earnings per share of ($0.06) in the same quarter last year, which would indicate a negative year-over-year growth rate of 116.7%. The business is expected to issue its next quarterly earnings report on Tuesday, November 5th.

On average, analysts expect that TrueCar will report full year earnings of ($0.58) per share for the current fiscal year, with EPS estimates ranging from ($0.71) to ($0.32). For the next financial year, analysts anticipate that the company will report earnings of ($0.42) per share, with EPS estimates ranging from ($0.50) to ($0.23). Zacks’ EPS averages are a mean average based on a survey of research analysts that cover TrueCar.

TrueCar (NASDAQ:TRUE) last announced its quarterly earnings data on Thursday, August 8th. The technology company reported ($0.02) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.08) by $0.06. TrueCar had a negative net margin of 14.25% and a negative return on equity of 11.45%. The business had revenue of $88.08 million for the quarter, compared to analyst estimates of $89.20 million. During the same period last year, the business earned $0.03 EPS. The company’s revenue was up .3% on a year-over-year basis.

A number of research analysts recently commented on the stock. ValuEngine raised shares of TrueCar from a “sell” rating to a “hold” rating in a research report on Thursday, August 1st. Zacks Investment Research downgraded shares of TrueCar from a “hold” rating to a “sell” rating in a research report on Saturday, July 27th. Cowen set a $5.00 target price on shares of TrueCar and gave the company a “hold” rating in a research report on Friday, August 9th. Needham & Company LLC started coverage on shares of TrueCar in a research report on Thursday. They set a “hold” rating on the stock. Finally, TheStreet downgraded shares of TrueCar from a “c-” rating to a “d” rating in a report on Thursday, August 8th. Two analysts have rated the stock with a sell rating and ten have given a hold rating to the company. TrueCar presently has a consensus rating of “Hold” and a consensus target price of $8.71.

Shares of TRUE traded up $0.07 during midday trading on Tuesday, reaching $4.33. The stock had a trading volume of 709,727 shares, compared to its average volume of 1,261,072. TrueCar has a 1-year low of $3.01 and a 1-year high of $14.55. The company’s fifty day simple moving average is $4.24 and its two-hundred day simple moving average is $5.71. The company has a debt-to-equity ratio of 0.12, a current ratio of 3.09 and a quick ratio of 3.09.

In related news, EVP Robert Mcclung sold 7,669 shares of the firm’s stock in a transaction dated Tuesday, June 18th. The shares were sold at an average price of $5.41, for a total value of $41,489.29. Following the completion of the sale, the executive vice president now owns 121,744 shares in the company, valued at $658,635.04. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 7.00% of the stock is owned by company insiders.

Large investors have recently bought and sold shares of the company. UBS Group AG grew its holdings in TrueCar by 90.8% in the second quarter. UBS Group AG now owns 4,882,365 shares of the technology company’s stock valued at $26,657,000 after purchasing an additional 2,323,218 shares during the period. Voloridge Investment Management LLC raised its holdings in TrueCar by 52.7% in the second quarter. Voloridge Investment Management LLC now owns 72,650 shares of the technology company’s stock valued at $397,000 after acquiring an additional 25,066 shares in the last quarter. Nuveen Asset Management LLC acquired a new stake in TrueCar in the second quarter valued at $2,142,000. UBS Asset Management Americas Inc. raised its holdings in TrueCar by 124.3% in the second quarter. UBS Asset Management Americas Inc. now owns 86,382 shares of the technology company’s stock valued at $472,000 after acquiring an additional 47,870 shares in the last quarter. Finally, D. E. Shaw & Co. Inc. raised its holdings in TrueCar by 46.1% in the second quarter. D. E. Shaw & Co. Inc. now owns 2,405,849 shares of the technology company’s stock valued at $13,136,000 after acquiring an additional 759,244 shares in the last quarter. 90.74% of the stock is owned by institutional investors and hedge funds.

About TrueCar

TrueCar, Inc, together with its subsidiaries, operates as an Internet-based information, technology, and communication services company in the United States. It operates its platform on the TrueCar Website and mobile applications. The company also customizes and operates its platform for its affinity group marketing partners, including financial institutions, membership-based organizations, and employee buying programs for large enterprises.

Read More: How does quantitative easing work?

Get a free copy of the Zacks research report on TrueCar (TRUE)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for TrueCar (NASDAQ:TRUE)

Receive News & Ratings for TrueCar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TrueCar and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Investment Analysts’ Price Target Changes for October, 14th
Investment Analysts’ Price Target Changes for October, 14th
Civic  Market Cap Achieves $26.92 Million
Civic Market Cap Achieves $26.92 Million
TRAXIA Tops 24-Hour Trading Volume of $207.00
TRAXIA Tops 24-Hour Trading Volume of $207.00
TOP  Price Hits $0.0022
TOP Price Hits $0.0022
Syndax Pharmaceuticals  Stock Rating Upgraded by Zacks Investment Research
Syndax Pharmaceuticals Stock Rating Upgraded by Zacks Investment Research
Laboratory Corp. of America  Stock Rating Upgraded by Zacks Investment Research
Laboratory Corp. of America Stock Rating Upgraded by Zacks Investment Research


 
© 2006-2019 Zolmax.